-
CASMC – Human Coronary Artery Smooth Muscle CellsCatalog #: CC-2583CASMC, Coronary Artery Smooth Muscle CellsSales unit: each
-
HMVEC-L – Human Lung Microvascular Endothelial CellsCatalog #: CC-2527
Cryopreserved ampule of Human Lung Microvascular Endothelial Cells (HMVEC-L) containing ≥ 500,000 cells
Sales unit: each -
RPTEC - Human Renal Proximal Tubule Epithelial CellsCatalog #: CC-2553
Cryopreserved ampule of Human Renal Proximal Tubule Epithelial Cells (RPTEC) containing ≥ 500,000 cells
Do you need a modified version of this cell product, such as different vialing sizes, or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Sales unit: each -
hVIC - Human Valvular Interstitial CellsCatalog #: 00225974
Custom, made-to-order batch of Human Valvular Interstitial Cells
Sales unit: Ampule -
hAoVEC - Human Aortic Valve Endothelial CellsCatalog #: 00225975
Custom, made-to-order batch of Human Aortic Valve Endothelial Cells
Sales unit: Ampule -
ADSC Growth Medium BulletKit™Catalog #: PT-4505
Culture system containing ADSC Basal Medium (PT-3273) and ADSC-GM SinglequotsTM Supplement Kit (PT-4503) required for growth of adipose-derived stem cells
Sales unit: kit -
-
Liver Mixed Non-parenchymal Cells, HumanCatalog #: HUCNPHuman cryopreserved liver mixed NPCs cellsSales unit: Ampule
-
Rat Neonatal Retinal CellsCatalog #: R-RET-508
Cryopreserved ampule of Rat Neonatal Retinal Cells containing ≥200,000 cells
Sales unit: each -
EBM™-2 Endothelial Cell Growth Basal Medium-2, 500 mLCatalog #: CC-3156EBM™-2 Endothelial Cell Growth Basal Medium recommended for growth of Endothelial cells (basal media only). Required growth factors and supplements sold seperately.Sales unit: each
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
-
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.